N/A
N=657
Measuring Cardiovascular Performance and Blood Flow Using Common But Never Compared Methods.
D012039 · D001775
Bottom Line
View on ClinicalTrials.gov: NCT04553484 ↗Enrolled (actual)
657
Serious AEs
0.0%
Results posted
Jul 2024
Primary outcome: Primary: Feasibility of Performing Echo, BNP, and VP on Human Subjects. — 657; 236 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- No intervention (Diagnostic_test)
- Age
- Adult, Older Adult · 45+ yrs
- Sex
- All
- Sponsor
- Semler Scientific
- Primary completion
- Dec 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility of Performing Echo, BNP, and VP on Human Subjects. |
657; 236 | — |
Summary
Measuring Cardiovascular Performance Using Common Methods in subjects.
Eligibility Criteria
Inclusion Criteria
- At least 50 Patients from New York Heart Association (NYHA) Class 1 (One or more AHA Risk Factors, asymptomatic), ≤75% (36) Male, ≥25% (12) Female
- At least 50 Patients from NYHA Class 2 (symptomatic), ≤75% (36) Male, ≥25% (12) Female
Exclusion Criteria
- Subjects on mechanical ventilation.
- Subjects who require decisions by a medical power of attorney.
- Subjects unable to safely perform forced expiration.
- Subjects with known technically difficult (TDS) trans-thoracic echocardiographic windows.
Data sourced from ClinicalTrials.gov (NCT04553484). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.